Publications

Faculty Publications

. Nguyen HM, Gaikwad S, Oladejo M, Agrawal MY, Srivastava SK, Wood LM.Cancer Lett. 2023 Mar 1;556:216080. doi: 10.1016/j.canlet.2023.216080. Epub 2023 Feb 1. PMID: 36736853
. Oladejo M, Paulishak W, Wood L. Semin Cancer Biol. 2023 Jan;88:81-95. doi: 10.1016/j.semcancer.2022.12.003. Epub 2022 Dec 13. PMID: 36526110
. Nguyen HM, Paulishak W, Oladejo M, Wood L. Breast Cancer. 2023 Mar;30(2):167-186. doi: 10.1007/s12282-022-01415-4. Epub 2022 Nov 18.PMID: 36399321
. Oladejo M, Nguyen HM, Seah H, Datta A, Wood LM.Cancer Immunol Immunother. 2023 Jun;72(6):1633-1646. doi: 10.1007/s00262-022-03356-5. Epub 2022 Dec 31.PMID: 36586013
. Nguyen HM, Gaikwad S, Oladejo M, Paulishak W, Wood LM.Cancers (Basel). 2023 Feb 15;15(4):1237. doi: 10.3390/cancers15041237.PMID: 36831577
. Oladejo M, Nguyen HM, Wood L. Cancer Lett. 2023 Jul 25:216327. doi: 10.1016/j.canlet.2023.216327. Online ahead of print.PMID: 37499740
. Noorani B, Chowdhury EA, Alqahtani F, Ahn Y, Nozohouri E, Zoubi S, Patel D, Wood L, Huang J, Siddique MB, Al-Ahmad A, Mehvar R, Bickel U.J Pharmacol Exp Ther. 2023 May;385(2):135-145. doi: 10.1124/jpet.122.001281. Epub 2023 Feb 24.PMID: 36828631
. Aburahma A, Rana S, Larsen R, Ward CS, Sprague JE.Eur J Pharmacol. 2023 Apr 15;945:175643. doi: 10.1016/j.ejphar.2023.175643. Epub 2023 Mar 5.PMID: 36882148
Astrinidis A, Li C, Zhang EY, Zhao X, Zhao S, Guo M, Olatoke T, Mattam U, Huang R, Zhang AG, Pitstick L, Kopras EJ, Gupta N, Jandarov R, Smith EP, Fugate E, Lindquist D, Markiewski MM, Karbowniczek M, Wikenheiser-Brokamp KA, Setchell KDR, McCormack FX, Xu Y, Yu JJ.JCI Insight. 2023 May 8;8(9):e166850. doi: 10.1172/jci.insight.166850.PMID: 36927688
. Olatoke T, Wagner A, Astrinidis A, Zhang EY, Guo M, Zhang AG, Mattam U, Kopras EJ, Gupta N, Smith EP, Karbowniczek M, Markiewski MM, Wikenheiser-Brokamp KA, Whitsett JA, McCormack FX, Xu Y, Yu JJ.Sci Adv. 2023 May 10;9(19):eadf8549. doi: 10.1126/sciadv.adf8549. Epub 2023 May 10.PMID: 37163604
. Srivastava SK, Kim SH. Semin Cancer Biol. 2023 Aug;93:1-2. doi: 10.1016/j.semcancer.2023.04.001. Epub 2023 Apr 7.PMID: 37031897
. Anderson KG, Braun DA, Buqu茅 A, Gitto SB, Guerriero JL, Horton B, Keenan BP, Kim TS, Overacre-Delgoffe A, Ruella M, Triplett TA, Veeranki O, Verma V, Zhang F.J Immunother Cancer. 2023 Jun;11(6):e006533. doi: 10.1136/jitc-2022-006533.PMID: 37399356
Holay N, Somma A, Duchow M, Soleimani M, Capasso A, Kottapalli S, Rios J, Giri U, Diamond J, Schreiber A, Piscopio AD, Van Den Berg C, Eckhardt SG, Triplett TA.
Anderson TS, McCormick AL, Daugherity EA, Oladejo M, Okpalanwaka IF, Smith SL, Appiah D, Wood LM, Lowe DB. OncoImmunology. 2023 Sep 28;12(1):2260620. doi: 10.1080/2162402X.2023.2260620. eCollection 2023.PMID: 37781234
Islam MR, Patel J, Back PI, Shmeeda H, Kallem RR, Shudde C, Markiewski M, Putnam WC, Gabizon AA, La-Beck NM. Biomolecules. 2023 Aug 26;13(9):1309. doi: 10.3390/biom13091309.PMID: 37759709
McCormick AL, Anderson TS, Daugherity EA, Okpalanwaka IF, Smith SL, Appiah D, Lowe DB. Front Immunol. 2023 Oct 2;14:1241949. doi: 10.3389/fimmu.2023.1241949. eCollection 2023.PMID: 37849752

Kaushik I, Ramachandran S, Zabel C, Gaikwad S, Srivastava SK. Semin Cancer Biol. 2022 Mar 24:S1044-579X(22)00076-1. doi: 10.1016/j.semcancer.2022.03.020. PMID: 35341912
Gaikwad S, Agrawal MY, Kaushik I, Ramachandran S, Srivastava SK. Semin Cancer Biol. 2022 Mar 24:S1044-579X(22)00070-0. doi: 10.1016/j.semcancer.2022.03.014. PMID: 35341913
Kaushik I, Srivastava SK. Mol Ther. 2022 Jul 6;30(7):2584-2602. doi: 10.1016/j.ymthe.2022.03.012. Epub 2022 Mar 21. PMID: 35331907
Anderson TS, Wooster AL, Piersall SL, Okpalanwaka F, Lowe D. DOI: 10.1016/j.semcancer.2022.02.009. PMID: 35149179
Agrawal MY, Gaikwad S, Srivastava S, Srivastava SK. doi: 10.3390/cancers14225482. PMID: 36428575
Kolev M, Das M, Gerber M, Baver S, Deschatelets P, Markiewski MM. doi: 10.3389/fimmu.2022.931273. eCollection 2022. PMID: 35860237
Oladejo M, Nguyen HM, Silwal A, Reese B, Paulishak W, Markiewski MM, Wood LM. doi: 10.3389/fimmu.2022.1038807. eCollection 2022. PMID: 36439126
Nguyen HM, Oladejo M, Paulishak W, Wood LM. doi: 10.1007/s00262-022-03352-9. PMID: 36562824.
Oladejo M, Nguyen HM, Seah H, Datta A, Wood LM. doi: 10.1007/s00262-022-03356-5. PMID: 36586013.
Nguyen HM, Paulishak W, Oladejo M, Wood L. doi: 10.1007/s12282-022-01415-4. PMID: 36399321.
Oladejo M, Paulishak W, Wood L. doi: 10.1016/j.semcancer.2022.12.003. PMID: 36526110
Md Rakibul Islam 1, Jalpa Patel 1, Patricia Ines Back 1, Hilary Shmeeda 2, Konstantin Adamsky 3, Hui Yang 4, Carlos Alvarez 4, Alberto A Gabizon 2 3, Ninh M La-Beck 1 4 PMID: 36105861
. Bazzi SA, Maguire C, Holay N, Geltman J, Hurley K, DiPasquale C, Abigania M, Olson E, Ehrlich LIR, Triplett TA, Melamed E. Mult Scler Relat Disord. 2022 Dec;68:104195. doi: 10.1016/j.msard.2022.104195. Epub 2022 Sep 26.PMID: 36223705
. Soleimani M, Somma A, Kaoud T, Goyal R, Bustamante J, Wylie DC, Holay N, Looney A, Giri U, Triplett T, Dalby K, Kowalski J, Eckhardt SG, Van Den Berg C.Mol Cancer Ther. 2022 Oct 7;21(10):1547-1560. doi: 10.1158/1535-7163.MCT-21-1044.PMID: 35977156

La-Beck NM, Liu X, Shmeeda H, Shudde C, Gabizon AA. Semin Cancer Biol. 2021 Jan;68:175-185. doi: 10.1016/j.semcancer.2019.12.001. Epub 2019 Dec 23.PMID: 31874280
La-Beck NM, Islam MR, Markiewski MM.Front Immunol. 2021 Jan 8;11:603039. doi: 10.3389/fimmu.2020.603039. eCollection 2020.PMID: 33488603
.Anderson TS, Wooster AL, La-Beck NM, Saha D, Lowe DB.Melanoma Res. 2021 Feb 1;31(1):1-17. doi: 10.1097/CMR.0000000000000702.PMID: 33165241
.Wooster AL, Girgis LH, Brazeale H, Anderson TS, Wood LM, Lowe DB. Pharmacol Res. 2021 Feb;164:105374. doi: 10.1016/j.phrs.2020.105374. Epub 2020 Dec 28.PMID: 33348026
.Nguyen HM, Guz-Montgomery K, Lowe DB, Saha D.Cancers (Basel). 2021 Feb 18;13(4):856. doi: 10.3390/cancers13040856.PMID: 33670551
.Nguyen HM, Saha D. Oncolytic Virother. 2021 Feb 24;10:1-27. doi: 10.2147/OV.S268426. eCollection 2021.PMID: 33659221
.Shaw V, Srivastava S, Srivastava SK. Semin Cancer Biol. 2021 Jan;68:75-83. doi: 10.1016/j.semcancer.2019.10.007. Epub 2019 Oct 13.PMID: 31618686
.Srivastava SK. Semin Cancer Biol. 2021 Jan;68:1-2. doi: 10.1016/j.semcancer.2020.07.008. Epub 2020 Jul 15.PMID: 32679189

Markiewski MM, Daugherity E, Reese B, Karbowniczek M.Antibodies (Basel). 2020 Dec 1;9(4):67. doi: 10.3390/antib9040067.PMID: 33271774 Free PMC article. Review.
.Ghouse SM, Vadrevu SK, Manne S, Reese B, Patel J, Patel B, Silwal A, Lodhi N, Paterson Y, Srivastava SK, Karbowniczek M, Markiewski MM.J Immunol. 2020 Feb 15;204(4):990-1000. doi: 10.4049/jimmunol.1901208. Epub 2020 Jan 3.PMID: 31900334
.Reese B, Silwal A, Daugherity E, Daugherity M, Arabi M, Daly P, Paterson Y, Woolford L, Christie A, Elias R, Brugarolas J, Wang T, Karbowniczek M, Markiewski MM.J Immunol. 2020 Dec 1;205(11):3218-3229. doi: 10.4049/jimmunol.2000511. Epub 2020 Nov 6.PMID: 33158953
.Gabizon AA, de Rosales RTM, La-Beck NM.Adv Drug Deliv Rev. 2020;158:140-157. doi: 10.1016/j.addr.2020.05.012. Epub 2020 Jun 9.PMID: 32526450
.La-Beck NM, Nguyen DT, Le AD, Alzghari SK, Trinh ST.Pharmacotherapy. 2020 Mar;40(3):239-255. doi: 10.1002/phar.2364. Epub 2020 Jan 29.PMID: 31930528
.Cavitt TB, Carlisle JG, Dodds AR, Faulkner RA, Garfield TC, Ghebranious VN, Hendley PR, Henry EB, Holt CJ, Lowe JR, Lowry JA, Oskin DS, Patel PR, Smith D, Wei W. iScience. 2020 Oct 20;23(11):101702. doi: 10.1016/j.isci.2020.101702. eCollection 2020 Nov 20.PMID: 33205020
.Rolfe BE, Pio R, Woodruff TM, Markiewski MM, Manthey HD.Front Immunol. 2020 Feb 11;11:139. doi: 10.3389/fimmu.2020.00139. eCollection 2020.PMID: 32117286
.Nguyen HM, Guz-Montgomery K, Saha D.Cells. 2020 Feb 10;9(2):400. doi: 10.3390/cells9020400.PMID: 32050597
.Ghouse SM, Nguyen HM, Bommareddy PK, Guz-Montgomery K, Saha D.Front Oncol. 2020 Mar 24;10:384. doi: 10.3389/fonc.2020.00384. eCollection 2020.PMID: 32266155
.Saha D, Rabkin SD, Martuza RL.J Immunother Cancer. 2020 May;8(1):e000345. doi: 10.1136/jitc-2019-000345.PMID: 32457126
.Saha D, Rabkin SD.Methods Mol Biol. 2020;2058:179-190. doi: 10.1007/978-1-4939-9794-7_11.PMID: 31486038
.Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165424. doi: 10.1016/j.bbadis.2019.02.019. Epub 2019 Feb 26.PMID: 30818002
.Prasad S, Srivastava SK.Antioxidants (Basel). 2020 Jan 13;9(1):72. doi: 10.3390/antiox9010072.PMID: 31941067
.Kaushik I, Ramachandran S, Prasad S, Srivastava SK. Semin Cancer Biol. 2021 Jan;68:279-290. doi: 10.1016/j.semcancer.2020.03.011. Epub 2020 May 11.PMID: 32437876 Review
.Srivastava S, Zahra FT, Gupta N, Tullar PE, Srivastava SK, Mikelis CM.Int J Mol Sci. 2020 Jan 23;21(3):755. doi: 10.3390/ijms21030755.PMID: 31979394
.Ranjan A, Kaushik I, Srivastava SK.Cells. 2020 Sep 22;9(9):2141. doi: 10.3390/cells9092141.PMID: 32971907

. Cho JH, Patel B, Bonala S, Mansouri H, Manne S, Vadrevu SK, Ghouse S, Kung CP, Murphy ME, Astrinidis A, Henske, Kwiatkowski DJ, Markiewski MM, Karbowniczek M. Mol Cancer Res. 2019 Aug: 17(8): 1639-1651. doi: 10.1158/1541-7786. MCR-18-1292. Epub 2019 May 14.
La-Beck NM, Liu X, Wood LM.Front Pharmacol. 2019 Mar 12;10:220. doi: 10.3389/fphar.2019.00220. eCollection 2019.PMID: 30914953
.Bommareddy PK, Lowe DB, Kaufman HL, Rabkin SD, Saha D.J Biol Methods. 2019;6(2):e112. doi: 10.14440/jbm.2019.281. Epub 2019 Apr 4.PMID: 31123687
.Wooster AL, Anderson TS, Lowe DB.J Immunol Methods. 2019 Jan;464:22-30. doi: 10.1016/j.jim.2018.10.006. Epub 2018 Oct 19.PMID: 30347189
.Bommareddy PK, Lowe DB, Kaufman HL, Rabkin SD, Saha D.J Biol Methods. 2019;6(2):e112. doi: 10.14440/jbm.2019.281. Epub 2019 Apr 4.PMID: 31123687
.Jahan N, Talat H, Alonso A, Saha D, Curry WT. Oncolmmunology. 2019 Feb 27;8(5):e1577108. doi: 10.1080/2162402X.2019.1577108. eCollection 2019.PMID: 31069135
.Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, Das H, Srivastava S, Prasad S, Srivastava SK.Int J Mol Sci. 2019 Oct 9;20(20):4981. doi: 10.3390/ijms20204981.PMID: 31600949
.Kaushik I, Ramachandran S, Srivastava SK. Semin Cell Dev Biol. 2019 Dec;96:4-12. doi: 10.1016/j.semcdb.2019.04.018. Epub 2019 May 4.PMID: 31054324
.Gupta N, Gupta P, Srivastava SK.Sci Rep. 2019 Mar 25;9(1):5066. doi: 10.1038/s41598-019-41632-0.PMID: 30911062
.Gupta N, Srivastava SK.Mol Cancer Ther. 2019 Oct;18(10):1708-1720. doi: 10.1158/1535-7163.MCT-18-1286. Epub 2019 Jul 3.PMID: 31270151
.Gupta P, Gupta N, Fofaria NM, Ranjan A, Srivastava SK.Cancer Lett. 2019 Feb 1;442:68-81. doi: 10.1016/j.canlet.2018.10.021. Epub 2018 Oct 26.PMID: 30409762

.Kochanek DM, Ghouse SM, Karbowniczek MM, Markiewski MM.Front Immunol. 2018 Jul 16;9:1629. doi: 10.3389/fimmu.2018.01629. eCollection 2018.PMID: 30061895 Free PMC article. Review.
.Kolev M, Markiewski MM. Semin Immunol. 2018 Jun;37:85-97. doi: 10.1016/j.smim.2018.02.003. Epub 2018 Feb 15.PMID: 29454575
.Kim CG, Lee H, Gupta N, Ramachandran S, Kaushik I, Srivastava S, Kim SH, Srivastava SK. Semin Cancer Biol. 2018 Jun;50:142-151. doi: 10.1016/j.semcancer.2017.07.007. Epub 2017 Aug 1.PMID: 28774834
.Verma K, Gupta N, Zang T, Wangtrakluldee P, Srivastava SK, Penning TM, Trippier PC.Mol Cancer Ther. 2018 Sep;17(9):1833-1845. doi: 10.1158/1535-7163.MCT-17-1023. Epub 2018 Jun 11.PMID: 29891491
.Jung JH, Jung DB, Kim H, Lee H, Kang SE, Srivastava SK, Yun M, Kim SH.Oncogene. 2018 Jul;37(27):3715-3728. doi: 10.1038/s41388-018-0225-0. Epub 2018 Apr 9.PMID: 29628506
Kwon HY, Kim JH, Kim B, Srivastava SK, Kim SH.Arch Toxicol. 2018 Jan;92(1):241-257. doi: 10.1007/s00204-017-2021-y. Epub 2017 Jul 4.PMID: 28676953

.Cho JH, Patel B, Bonala S, Manne S, Zhou Y, Vadrevu SK, Patel J, Peronaci M, Ghouse S, Henske EP, Roegiers F, Giannikou K, Kwiatkowski DJ, Mansouri H, Markiewski MM, White B, Karbowniczek M. Nat Commun. 2017 Nov 29;8(1):1848. doi: 10.1038/s41467-017-01845-1.PMID: 29184052
.Markiewski MM, Vadrevu SK, Sharma SK, Chintala NK, Ghouse S, Cho JH, Fairlie DP, Paterson Y, Astrinidis A, Karbowniczek M.J Immunol. 2017 Apr 1;198(7):2989-2999. doi: 10.4049/jimmunol.1602057. Epub 2017 Feb 22.PMID: 28228558
.Trinh S, Le A, Gowani S, La-Beck NM.Asia Pac J Oncol Nurs. 2019 Apr-Jun;6(2):154-160. doi: 10.4103/apjon.apjon_3_19.PMID: 30931360
.Le AD, Alzghari SK, Jean GW, La-Beck NM. Ther Clin Risk Manag. 2017 Feb 21;13:223-236. doi: 10.2147/TCRM.S104343. eCollection 2017.PMID: 28260909
.Lowe DB, Bivens CK, Mobley AS, Herrera CE, McCormick AL, Wichner T, Sabnani MK, Wood LM, Weidanz JA. MAbs. 2017 May/Jun;9(4):603-614. doi: 10.1080/19420862.2017.1302630.PMID: 28273004
.Rajan R, Sabnani MK, Mavinkurve V, Shmeeda H, Mansouri H, Bonkoungou S, Le AD, Wood LM, Gabizon AA, La-Beck NM.J Control Release. 2018 Feb 10;271:139-148. doi: 10.1016/j.jconrel.2017.12.023. Epub 2017 Dec 23.PMID: 29277680
.Ranjan A, Srivastava SK. Oncotarget. 2017 May 16;8(20):32960-32976. doi: 10.18632/oncotarget.16515.PMID: 28380428
.Ranjan A, German N, Mikelis C, Srivenugopal K, Srivastava SK. Tumour Biol. 2017 Jun;39(6):1010428317705517. doi: 10.1177/1010428317705517.PMID: 28618969
.Ranjan A, Wright S, Srivastava SK. Oncotarget. 2017 Jul 18;8(29):47632-47641. doi: 10.18632/oncotarget.17425.PMID: 28512255

.Patel B, Patel J, Cho JH, Manne S, Bonala S, Henske E, Roegiers F, Markiewski M, Karbowniczek M. Oncogene. 2016 Jun 9;35(23):3027-36. doi: 10.1038/onc.2015.358. Epub 2015 Oct 5.PMID: 26434588
.Gabizon AA, Patil Y, La-Beck NM.Drug Resist Updat. 2016 Nov;29:90-106. doi: 10.1016/j.drup.2016.10.003. Epub 2016 Oct 29.PMID: 27912846
.Ranjan A, Srivastava SK.Sci Rep. 2016 May 18;6:26165. doi: 10.1038/srep26165.PMID: 27189859
.Fofaria NM, Qhattal HS, Liu X, Srivastava SK.Int J Pharm. 2016 Feb 10;498(1-2):12-22. doi: 10.1016/j.ijpharm.2015.11.045. Epub 2015 Nov 28.PMID: 26642946
.Ranjan A, Gupta P, Srivastava SK.Cancer Res. 2016 Feb 15;76(4):877-90. doi: 10.1158/0008-5472.CAN-15-1233. Epub 2015 Dec 1.PMID: 26627008

.Sharma SK, Chintala NK, Vadrevu SK, Patel J, Karbowniczek M, Markiewski MM.J Immunol. 2015 Jun 1;194(11):5529-38. doi: 10.4049/jimmunol.1403215. Epub 2015 Apr 24.PMID: 25911761
.Rajan R, Karbowniczek M, Pugsley HR, Sabnani MK, Astrinidis A, La-Beck NM. Cytometry A. 2015 May;87(5):451-8. doi: 10.1002/cyto.a.22652. Epub 2015 Feb 27.PMID: 25728685
.La-Beck NM, Jean GW, Huynh C, Alzghari SK, Lowe DB.Pharmacotherapy. 2015 Oct;35(10):963-76. doi: 10.1002/phar.1643.PMID: 26497482
.Villarreal DO, Wise MC, Siefert RJ, Yan J, Wood LM, Weiner DB, Mol Ther. 2015 Oct;23(10):1653-62. doi: 10.1038/mt.2015.120. Epub 2015 Jun 30.PMID: 26122932
.Sabnani MK, Rajan R, Rowland B, Mavinkurve V, Wood LM, Gabizon AA, La-Beck NM. Nanomedicine. 2015 Feb;11(2):259-62. doi: 10.1016/j.nano.2014.08.010. Epub 2014 Sep 6.PMID: 25200609
.Ranjan A, Fofaria NM, Kim SH, Srivastava SK.Chin J Nat Med. 2015 Oct;13(10):730-42. doi: 10.1016/S1875-5364(15)30073-X.PMID: 26481373
.Fofaria NM, Ranjan A, Kim SH, Srivastava SK.Enzymes. 2015;37:111-37. doi: 10.1016/bs.enz.2015.06.001. Epub 2015 Jul 7.PMID: 26298458
.Gupta P, Wright SE, Srivastava SK. OncoImmunology. 2015 Mar 6;4(2):e981449. doi: 10.4161/2162402X.2014.981449. eCollection 2015 Feb.PMID: 25949878
.Fofaria NM, Frederick DT, Sullivan RJ, Flaherty KT, Srivastava SK. Oncotarget. 2015 Dec 1;6(38):40535-56. doi: 10.18632/oncotarget.5755.PMID: 26497853
.Fofaria NM, Srivastava SK. Carcinogenesis. 2015 Jan;36(1):142-50. doi: 10.1093/carcin/bgu233. Epub 2014 Nov 19.PMID: 25411359
.Pramanik KC, Fofaria NM, Gupta P, Ranjan A, Kim SH, Srivastava SK. Oncotarget. 2015 May 10;6(13):11561-74. doi: 10.18632/oncotarget.3427.PMID: 25869100
.Jung JH, Yun M, Choo EJ, Kim SH, Jeong MS, Jung DB, Lee H, Kim EO, Kato N, Kim B, Srivastava SK, Kaihatsu K, Kim SH.Br J Pharmacol. 2015 Jul;172(14):3565-78. doi: 10.1111/bph.13146. Epub 2015 Jun 4.PMID: 25825203

Faculty Patents

Provisional Patent #62963258 Novel and potent JAK/STAT inhibitors.

US10,463,649 - Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors.

#PCT/US 2018: 60763 - Composition and methods for treating cancer. (Sanjay K. Srivastava)

Provisional Patent #62585080- Composition and methods for treating cancer. (Sanjay K. Srivastava)

PCT/US2016 #036002 - Inhibitors of Mcl-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors (Sanjay K. Srivastava)

#62/172,327 - Inhibitors of Mcl-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors (Sanjay K. Srivastava)
# 62/189,377 - Formulations of piperlongumine for oral and topical application for prevention and treatment of melanoma (Sanjay K. Srivastava)
#62026970 - Overcoming Chemotherapeutic Agent Resistance in Cancer by Inhibiting Mcl-1 (Sanjay K. Srivastava)

WO2014210411 A1 - Histone deacetylase inhibitors and methods of use (Sanjay K. Srivastava)
#61973672 - Overcoming vemurafenib resistance in metastatic cancers (Sanjay K. Srivastava)
#62026970 - Overcoming chemotherapeutic agent resistance in cancer by inhibiting Mcl-1 (Sanjay K. Srivastava)

#61840751 - Histone deacetylase inhibitors and methods of use (Sanjay K. Srivastava)
WO2013/074820 - Immunogenic tumor associated stromal cell antigen peptides and methods of their use. (WJ Storkus, A. Bose, JL Taylor, X Zhao, DB Lowe)

甜瓜视频

Publications

Faculty Publications

Faculty Patents